understand market concern ci miss light result across
group howev believ narrow focu fail appreci health svc
perform improv management expect contrast investor concern
result est ci hardli price perfect improv health
svc off-set concern
believ ci report solid result strength busi
enough overcom higher integr medic segment ep
like closer exclud one-tim out-of-period item relat
favor resolut tax matter worth ep posit prior year develop
worth neg risk adjust true up estim lower ep
repres solid beat rel consensu
howev sens share pressur today investor focus
integr medic miss even exclud out-of-period item posit prior year
develop neg risk adjust true relat membership
believ still miss consensu expect bp compani cite three
approxim equal driver higher quarter includ addit
express script pdp live integr medic segment impact season
impact hif holiday individu margin normal pdp typic higher
earlier year declin year progress season
less invers individu season suspect net impact could potenti
result steadier perform vs go forward fact
compani maintain guidanc seem suggest factor drive second
quarter miss rel consensu contempl guidanc perhap
fulli appreci street
say discount miss particularli sinc pattern
compani miss metric quarter even unifi theme individu
cite frequent variou reason still believ better
expect result enough send share higher today especi
given stock punish last month due concern
potenti rebat rule long-term viabil pbm model worri
exacerb appar oper earn y/i
surpris market recept stronger expect
result impli easier profit ramp reach
fact matter biggest drag multipl
sustain period time given repres major oper incom lead
roughli turn price-to-earnings multipl discount peer group howev improv
result guidanc mid-singl digit y/i ebit growth
pro-forma basi perform appear track slightli better overli bearish
expect head year full year estim y/i growth health
servic adjust oper incom pro-forma basi full-year guidanc
impli ebit growth double-digit rang acceler growth
pleas see page report import disclosur
posit share ci believ acquisit esrx posit compani
succeed evolv healthcar landscap stand-alon basi ci carv
strong posit market particularli aso recent result demonstr
abil deliv strong result led critic compani spend
billion acquir esrx reflect rel depress valuat compar peer
believ unwarr believ investor may give enough credit
near-term growth opportun yet outlin beyond million cost synergi
greater purchas scale esrx ci posit full-risk
aso market believ strateg valu esrx even potenti
near-term accret lie long-term posit market shift toward greater care
coordin value-bas care
oper earn grow y/i
grow y/i
stronger expect medic custom
realiz pre-tax cost synergi excess
integr challeng lower
expect synergi esrx deal
global health servic compani subsidiari offer medic dental
disabl life accid insur relat product servic
product servic offer employ group select
intern market offer supplement health life accid insur product
intern health care coverag servic busi government non-
government organ individu decemb acquir
script largest pharmaci benefit manag script servic includ
drug util review formulari manag diseas manag medic drug
data analysi servic medic inform manag servic oper five
segment integr medic intern market oper
corpor
rais full year adj ep estim
estim increas maintain price target impli
price-to-earnings multipl adj ep stock current trade
adj ep estim suggest signific upsid believ valuat attract
biggest drag multipl last month segment appear
pois least meet possibl exceed expect believ even factor
concern miss stronger outlook reflect
current valuat believ valuat discount peer start close
million except per-shar data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end decemb cowen
million except per-shar data
cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom incom adjust oper share outstand fulli net incom reconcili net chang servic incom end decemb cowen
million except per-shar data
compani report cowen compani
invest cost benefit expens servic pharmaci oper non-control interest incom pre-tax adjust oper net non-control interest incom loss adjust incom adjust oper share outstand fulli net incom reconcili amort acquir intang realiz gain chang y/i invest cost benefit servic pre-tax incom cowen
million
compani report cowen compani
receiv current polici acquisit tax asset asset account insur contracthold servic cost expens insur contracthold tax liabil non-curr account non-controlling equitycommon paid comprehens treasuri stock sharehold liabil sharehold liquid ratio current receiv claim payabl structur long-term solvenc ratio return invest capit averag total asset averag stockhold equiti end decemb cowen
million
compani report cowen compani
invest gain incom extinguish chang asset liabil net non-oper effect account polici acquisit servic cost payabl accru expens oper net cash equip purchas invest repay debt common common foreign currenc rate chang cash cash increas decreas end decemb cowen
million
compani report cowen compani
invest gain loss incom tax benefit extinguish chang asset liabil net non-oper effect account polici acquisit servic cost payabl accru expens oper invest sold fix matur equiti matur repay fix matur equiti sale matur purchas fix matur equiti primarili short-term equip net cash invest interest credit contracthold deposit benefit payment contracthold deposit chang short-term debt long-term proce issuanc long-term common common financ foreign currenc rate chang cash cash increas decreas cowen
valu manag care stock use pe multipl forward earn manag care
sector trade averag forward year earn past year
peak trough troubl econom time
frame given reform-rel multi-year top-lin growth prospect believ sector
trade high end recent histor valuat
success individu public exchang remain consider question mark
head third year program final year two three premium
stabil program reinsur risk corridor although exchang profit
expect improv expect continu money lose enterpris
industri particip receipt risk corridor payment remain potenti threat
success compani reli receiv medicar advantag payment
reduct includ potenti introduct new risk adjust model could
reduc futur medicar advantag margin growth prospect rel expect
gener medicaid payment expans popul gener
howev mount evid state like reduc payment level
medic cost trend mute past year uptick underli
medic cost may difficult predict product price within commerci
integr esrx anoth potenti risk particularli compani eventu move
ci live onto esrx platform also begin march began transit
membership pbm ingeniorx support disrupt could
impact ci note esrx tsa run
transit work move would need negoti
potenti propos hh regard futur rebat could impact ci
would expect potenti impact headlin risk vs meaning impact
remain chanc administr could propos sweep broad new
